Science Translational Medicine 11 Sep 2019: Vol. 11, Issue 509, eaaw8412 "Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials" [Abstract] This paper elucidated that 10 drugs inhibit proliferation …